ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,037.88
      0.72%
      US Tech 100
      20,796.80
      -0.87%
      Dow Jones
      44,556.04
      0.30%
      Brent Oil
      75.405
      -0.70%
      Bitcoin
      97,882.15
      0.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Impact Biomedical Inc (IBO) Quote

      Impact Biomedical Inc

      Impact Biomedical Inc (IBO)

      Universal Ibogaine Inc
      1.965
      0.44
      (28.43%)
      Closed February 04 4:00PM
      Delayed by 15 minutes
      1.965
      0.00
      ( 0.00% )
      Pre Market: 5:32AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.965
      Bid
      -
      Ask
      -
      Volume
      2
      0.00 Day's Range 0.00
      1.16 52 Week Range 3.25
      Previous Close
      1.965
      Open
      -
      Last Trade
      2
      @
      1.89
      Last Trade Time
      04:15:53
      Average Volume (3m)
      33,925
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      IBO Latest News

      More News

      Form 8-K - Current report

      January 29 2025
      Edgar (US Regulatory)

      Form S-8 - Securities to be offered to employees in employee benefit plans

      January 24 2025
      Edgar (US Regulatory)

      Impact BioMedical Inc. to Present at The Microcap Conference

      HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

      January 23 2025
      GlobeNewswire Inc.

      Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

      HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

      November 19 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 04 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

      HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

      October 15 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 08 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

      HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

      October 07 2024
      GlobeNewswire Inc.

      Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

      HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

      September 26 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.1357.377049180331.832.151.4991266941.81584071CS
      4-0.055-2.722772277232.022.181.45175401.73039092CS
      12-0.685-25.84905660382.653.251.16339252.15618454CS
      26-1.035-34.533.251.16644422.20567328CS
      52-1.035-34.533.251.16644422.20567328CS
      156-1.035-34.533.251.16644422.20567328CS
      260-1.035-34.533.251.16644422.20567328CS

      IBO - Frequently Asked Questions (FAQ)

      What is the current Impact Biomedical share price?
      The current share price of Impact Biomedical is $ 1.965
      What is the 1 year trading range for Impact Biomedical share price?
      Impact Biomedical has traded in the range of $ 1.16 to $ 3.25 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      OGENOragenics Inc
      $ 0.5086
      (79.02%)
      		20.14M
      GPUSHyperscale Data Inc
      $ 5.00
      (27.23%)
      		5
      MXCMexco Energy Corp
      $ 14.98
      (23.90%)
      		5
      WYYWidePoint Corporation
      $ 4.27
      (10.62%)
      		3
      IORIncome Opportunity Realty Investments
      $ 19.85
      (10.03%)
      		17
      SVTServotronics Inc
      $ 8.11
      (-22.76%)
      		11
      EVIEVI Industries Inc
      $ 14.10
      (-19.57%)
      		7
      AZTRAzitra Inc
      $ 0.2655
      (-18.06%)
      		339.99k
      GOOXT Rex 2x Long Alphabet Daily Target ETF
      $ 31.77
      (-14.53%)
      		1.74k
      ARENArena Group Holdings Inc
      $ 1.22
      (-14.08%)
      		175
      OGENOragenics Inc
      $ 0.5086
      (79.02%)
      		20.14M
      ETHU2x Ether ETF
      $ 4.76
      (2.81%)
      		1.97M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 25.97
      (-1.07%)
      		1.13M
      SOXSDirexion Daily Semiconductor Bear 3X Shares New
      $ 21.35
      (1.18%)
      		526.86k
      UVXYProShares Ultra VIX Short Term Futures ETF
      $ 19.75
      (3.40%)
      		491.92k

      IBO Discussion

      View Posts
      Disquisition Disquisition 4 months ago
      INCREDIBLE DUMPING
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      IBO...BOTTOM BOUNCER
      👍️0
      rizah rizah 2 years ago
      All resolutions were approved by the required majority of shareholders at Universal Ibogaine Inc.'s (IBO)annual general meeting ("AGM"), which was held on October 3, 2022 in Vancouver, British Columbia. The company is a life sciences company with a mission to provide medicalized ibogaine-centered addiction care.
      👍️0
      harry_brat harry_brat 3 years ago
      $IBO held on to its renowned capital market advisor

      UI recently announced that it has retained Mr. Shayne Nyquvest as their capital market advisor in a consulting role. Mr. Nyquvest has substantial capital markets experience, having assisted companies in the mining, cannabis, and other growing industries with strategic fund-raising initiatives for over 4 decades.
      👍️0
      Blue_Digital_Media Blue_Digital_Media 3 years ago
      Universal Ibogaine Inc. thanks to David for his contributions to the Company during his tenure as a Director.

      Watch now IBO for latest stock information.
      👍️0

      Your Recent History

      AMEX
      IBO
      Impact Biomedical
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads